Nikos Athanasou

Last updated

Nikos Athanasou (born 1953) is an Australian short story writer and novelist and musculoskeletal pathologist and scientist. He was born in Perth and grew up in Sydney where he studied medicine. He moved to England and is currently Professor of Musculoskeletal Pathology at Oxford University and a Fellow of Wadham College.

Contents

Short story writer and novelist

His collection of twenty short stories Hybrids [1] was published in 1995. These character-based short stories dealt with the sense of dislocation felt by Greek Australians and Greeks in Australia who see themselves as neither wholly Greek nor Australian but as a specific hybrid species formed to a greater or lesser extent by the influence of these two cultures. Greek traditions sit uneasily in the new world society of Australia and contrarily, Australian attitudes and outlook clash with the social customs and attitudes of Greeks. In 2024, Athanasou published a second collection of twenty short stories, "Late Hybrids" which highlighted not just cultural differences amongst later generation Greek-Australians, Greeks and Australians but also the distinctive psyche of Greek Australians when they encounter issues of life, love, death and duty to one’s past [2]

His first novel, The Greek Liar, [3] was published in 2002. It examined Greek Australian society and examined the effect of Greek social structures and the pursuit of materialistic goals on the Greek-Australian quest for identity.

His second novel The Person of the Man, [4] published in 2012, continues this existential theme, examining the feelings underlying an outwardly successful but secretly flawed marriage. The betrayal and tragedy that follow show that love cannot be analysed: it can only be understood.

His third novel Palindrome, [5] published in 2016 is a cerebral crime novel set in the none too virtuous world of modern Oxford town and gown.

Musculoskeletal pathologist and scientist

As Nicholas Athanasou he has written widely on bone, joint and soft tissue pathology and on the pathobiology of osteoarticular cells and tissues. [6] [7] With TJ Chambers he developed the osteoclast lacunar bone resorption assay system. [8] His work was the first to show that the human osteoclast shares specific surface antigens with macrophages and that the mononuclear human osteoclast precursor circulates in the (CD14+) monocyte fraction. [9] [10] [11] This led to the discovery of cellular and molecular mechanisms of pathological bone resorption associated with primary and secondary bone tumours, particularly breast cancer metastasis, [12] [13] Ewing sarcoma [14] and giant cell–rich lesions such as giant cell tumour of bone and pigmented villonodular synovitis. [15] [16] In addition, his work has studied synovial and inflammatory macrophages and their role in osteoarthritis, rheumatoid arthritis, infection and Paget disease. [17] [18] [19] [20] His work on hip and knee implants focused on the importance of biomaterial wear particles on promoting osteoclast formation, osteolysis and implant loosening. [21] [22] He also characterised inflammatory criteria for the histological diagnosis of infection using frozen section procedure [23] [24] and was the first to provide a pathological description of pseudotumors associated with metal on metal hip implants. [25] [26]

Sources

  1. Nikos Athanasou (1995) Hybrids. Brandl and Schlesinger. ISBN   0646238922
  2. Athanasou, Nicholas (April 2024). Late Hybrids. Brandl & Schlesinger. ISBN   0648202739.
  3. Nikos Athanasou (2002) The Greek Liar. Brandl and Schlesinger. ISBN   1876040416
  4. Nikos Athanasou (2012) The Person of the Man. Brandl and Schlesinger. ISBN   9781921556340
  5. Nick Athanasou (2016) Palindrome. Brandl and Schlesinger. ISBN   9781921556265
  6. Nicholas Athanasou (2001) The Pathological Basis of Orthopaedic and Rheumatic Disease. Arnold. ISBN   0340763825
  7. Nicholas Athanasou (1999) Colour Atlas of Bone, Joint and Soft Tissue Pathology. Oxford University Press. ISBN   0192627929
  8. Chambers TJ, Revell PA, Fuller K, Athanasou NA. (1984). Resorption of bone by isolated rabbit osteoclasts. J Cell Science 66: 383 – 399 PMID   6746762
  9. Athanasou NA, Quinn J. (1990). Immunophenotypic differences between osteoclasts and macrophage polykaryons: immunohistological distinction and implications for osteoclast ontogeny and function. J Clin Pathol 43: 997 – 1003 PMID   2266187
  10. Fujikawa Y, Quinn J, Sabokbar A, McGee JO'D, Athanasou NA. (1996) The human mononuclear osteoclast precursor circulates in the monocyte fraction. Endocrinology 139: 4058 -4060 PMID   8756585
  11. Athanasou N. (1996) The cellular biology of bone-resorbing cells. J Bone Joint Surgery (A). 78: 1096 – 1112 PMID   8698729
  12. Athanasou NA, Quinn J. (1992). Human tumour-associated macrophages are capable of bone resorption. Br J Cancer 65: 523 – 526 PMID   1562461
  13. Quinn JMW, McGee JO'D, Athanasou NA. (1998). Human tumour-associated macrophages differentiate into osteoclastic bone-resorbing cells. J Pathol 184: 31-36. PMID   9582524
  14. Taylor R, Knowles H, Athanasou NA (2011) Ewing sarcoma cells express RANKL and support osteoclastogenesis. J Pathol 225: 195-202 PMID   21547906
  15. Lau YS, Sabokbar A, Gibbons CLMH, Athanasou NA. (2005). Phenotypic and molecular studies on giant cell tumours of bone and soft tissues. Hum Pathol. 36: 945 – 954 PMID   16153456
  16. Taylor R, Knowles H, Kashima T, Gibbons CLMH, Whitewell D, Athanasou NA, (2011) Osteoclast formation and function in pigmented villonodular synovitis. J Pathol 225:151-156 PMID   21706481
  17. Fujikawa Y, Sabokbar A, Neale S, Athanasou NA. (1996) Human osteoclast formation and bone resorption by monocytes and synovial macrophages in rheumatoid arthritis. Ann Rheum Dis 55: 1 – 7 PMID   8976638
  18. Itonaga I, Fujikawa Y, Sabokbar A, Athanasou NA. (2000). The effect of osteoprotegerin and osteoprotegerin ligand on human arthroplasty macrophage-osteoclast differentiation. Ann Rheum Dis 59: 26 - 31. PMID   10627423
  19. Knowles H, Moskovsky L, Thompson MS, Grunhen J, Chen X, Kashima T, Athanasou NA (2012) Chondroclasts are mature osteoclasts which are capable of cartilage matrix resorption Virchows Archiv 46:205-210 PMID   22782381
  20. Sun SG, Lau YS, Itonaga I, Sabokbar A, Athanasou NA. (2006). Bone stromal cells in Paget's disease and Paget's sarcoma express RANKL and support human osteoclast formation. J Pathology 209: 114 – 120 PMID   16482498
  21. Sabokbar AS, Fujikawa Y, Neale S, Murray D, Athanasou NA. (1997) Human arthroplasty-derived macrophages differentiate into osteoclastic bone-resorbing cells. Ann Rheum Dis 56: 414 – 420 PMID   9486003
  22. Itonaga I, Fujikawa Y, Sabokbar A, Athanasou NA. (2000). Effect of osteoprotegerin and osteoprotegerin ligand on human arthroplasty macrophage-osteoclast differentiation. Ann Rheum Dis 59: 26 - 31 PMID   10627423
  23. Athanasou NA, Pandey R, de Steiger R, Crook D, McLardy-Smith P. (1995). The role of intraoperative frozen section diagnosis of infection in revision arthroplasty. J Bone Joint Surg (Br) 77B: 28-33 PMID   9314407
  24. Pandey R, Drakoulakis E, Athanasou NA. (1999). An assessment of the histological criteria used to diagnose infection in hip revision arthroplasty tissues. J Clin Pathol 52: 118 - 123 PMID   10396239
  25. Pandit H, Glyn-Jones S, McLardy-Smith P, Gundle R, Whitwell D, Gibbons CLMH, Ostlere S, Athanasou NA, Gill R, Murray D. W, (2008). Pseudotumours associated with metal-on-metal hip resurfacings. J Bone Joint Surg 90: 847-851 doi : 10.1302/0301-620X.90B7.20213 PMID   18591590
  26. Mahendra G, Pandit H, Kliskey K, Murray D, Gill HS, Athanasou NA (2009) Necrotic and inflammatory changes in metal-on-metal resurfacing hip arthroplasties: Relation to implant failure and pseudotumour formation. Acta Orthop. 80:653-9 PMID   19995315

Related Research Articles

<span class="mw-page-title-main">Bone</span> Rigid organs that constitute part of the endoskeleton of vertebrates

A bone is a rigid organ that constitutes part of the skeleton in most vertebrate animals. Bones protect the various other organs of the body, produce red and white blood cells, store minerals, provide structure and support for the body, and enable mobility. Bones come in a variety of shapes and sizes and have complex internal and external structures. They are lightweight yet strong and hard and serve multiple functions.

<span class="mw-page-title-main">Osteoblast</span> Cells secreting extracellular matrix

Osteoblasts are cells with a single nucleus that synthesize bone. However, in the process of bone formation, osteoblasts function in groups of connected cells. Individual cells cannot make bone. A group of organized osteoblasts together with the bone made by a unit of cells is usually called the osteon.

<span class="mw-page-title-main">Osteopetrosis</span> Rare disease of the bones

Osteopetrosis, literally 'stone bone', also known as marble bone disease or Albers-Schönberg disease, is an extremely rare inherited disorder whereby the bones harden, becoming denser, in contrast to more prevalent conditions like osteoporosis, in which the bones become less dense and more brittle, or osteomalacia, in which the bones soften. Osteopetrosis can cause bones to dissolve and break.

<span class="mw-page-title-main">Osteoclast</span> Cell that breaks down bone tissue

An osteoclast is a type of bone cell that breaks down bone tissue. This function is critical in the maintenance, repair, and remodeling of bones of the vertebral skeleton. The osteoclast disassembles and digests the composite of hydrated protein and mineral at a molecular level by secreting acid and a collagenase, a process known as bone resorption. This process also helps regulate the level of blood calcium.

<span class="mw-page-title-main">Osteoprotegerin</span> Mammalian protein found in Homo sapiens

Osteoprotegerin (OPG), also known as osteoclastogenesis inhibitory factor (OCIF) or tumour necrosis factor receptor superfamily member 11B (TNFRSF11B), is a cytokine receptor of the tumour necrosis factor (TNF) receptor superfamily encoded by the TNFRSF11B gene.

<span class="mw-page-title-main">Osteocyte</span> Mature osteoblasts which helps in communication between cells and also in molecular synthesis

An osteocyte, an oblate shaped type of bone cell with dendritic processes, is the most commonly found cell in mature bone. It can live as long as the organism itself. The adult human body has about 42 billion of them. Osteocytes do not divide and have an average half life of 25 years. They are derived from osteoprogenitor cells, some of which differentiate into active osteoblasts. Osteoblasts/osteocytes develop in mesenchyme.

<span class="mw-page-title-main">Dental follicle</span> Anatomical entity

The dental follicle, also known as dental sac, is made up of mesenchymal cells and fibres surrounding the enamel organ and dental papilla of a developing tooth. It is a vascular fibrous sac containing the developing tooth and its odontogenic organ. The dental follicle (DF) differentiates into the periodontal ligament. In addition, it may be the precursor of other cells of the periodontium, including osteoblasts, cementoblasts and fibroblasts. They develop into the alveolar bone, the cementum with Sharpey's fibers and the periodontal ligament fibers respectively. Similar to dental papilla, the dental follicle provides nutrition to the enamel organ and dental papilla and also have an extremely rich blood supply.

<span class="mw-page-title-main">Podosome</span>

Podosomes are conical, actin-rich structures found as appendages on the outer surface of the plasma membrane of animal cells. Their size ranges from approximately 0.5 μm to 2.0 μm in diameter. While usually situated on the periphery of the cellular membrane, these unique structures display a polarized pattern of distribution in migrating cells, situating at the front border between the lamellipodium and lamellum. Their primary purpose is connected to cellular motility and invasion; therefore, they serve as both sites of attachment and degradation along the extracellular matrix. Many different specialized cells exhibit these dynamic structures such as invadopodia,, osteoclasts, vascular smooth muscle cells, endothelial cells, and certain immune cells such as macrophages and dendritic cells.

<span class="mw-page-title-main">Alveolar process</span> Region of jaw bones containing tooth sockets

The alveolar process is the portion of bone containing the tooth sockets on the jaw bones. The alveolar process is covered by gums within the mouth, terminating roughly along the line of the mandibular canal. Partially comprising compact bone, it is penetrated by many small openings for blood vessels and connective fibres.

<span class="mw-page-title-main">Giant cell</span> Mass resulting from the fusion of many cells

A giant cell is a mass formed by the union of several distinct cells, often forming a granuloma.

<span class="mw-page-title-main">Bone resorption</span> Breakdown of bone tissue to be absorbed into the blood

Bone resorption is resorption of bone tissue, that is, the process by which osteoclasts break down the tissue in bones and release the minerals, resulting in a transfer of calcium from bone tissue to the blood.

<span class="mw-page-title-main">RANK</span> Mammalian protein found in Homo sapiens

Receptor activator of nuclear factor κ B (RANK), also known as TRANCE receptor or TNFRSF11A, is a member of the tumor necrosis factor receptor (TNFR) molecular sub-family. RANK is the receptor for RANK-Ligand (RANKL) and part of the RANK/RANKL/OPG signaling pathway that regulates osteoclast differentiation and activation. It is associated with bone remodeling and repair, immune cell function, lymph node development, thermal regulation, and mammary gland development. Osteoprotegerin (OPG) is a decoy receptor for RANKL, and regulates the stimulation of the RANK signaling pathway by competing for RANKL. The cytoplasmic domain of RANK binds TRAFs 1, 2, 3, 5, and 6 which transmit signals to downstream targets such as NF-κB and JNK.

<span class="mw-page-title-main">RANKL</span> Mammalian protein found in Homo sapiens

Receptor activator of nuclear factor kappa-Β ligand (RANKL), also known as tumor necrosis factor ligand superfamily member 11 (TNFSF11), TNF-related activation-induced cytokine (TRANCE), osteoprotegerin ligand (OPGL), and osteoclast differentiation factor (ODF), is a protein that in humans is encoded by the TNFSF11 gene.

<span class="mw-page-title-main">Tartrate-resistant acid phosphatase</span> Protein-coding gene in the species Homo sapiens

Tartrate-resistant acid phosphatase, also called acid phosphatase 5, tartrate resistant (ACP5), is a glycosylated monomeric metalloprotein enzyme expressed in mammals. It has a molecular weight of approximately 35kDa, a basic isoelectric point (7.6–9.5), and optimal activity in acidic conditions. TRAP is synthesized as latent proenzyme and activated by proteolytic cleavage and reduction. It is differentiated from other mammalian acid phosphatases by its resistance to inhibition by tartrate and by its molecular weight.

<span class="mw-page-title-main">CCL9</span> Mammalian protein found in Mus musculus

Chemokine ligand 9 (CCL9) is a small cytokine belonging to the CC chemokine family. It is also called macrophage inflammatory protein-1 gamma (MIP-1γ), macrophage inflammatory protein-related protein-2 (MRP-2) and CCF18, that has been described in rodents. CCL9 has also been previously designated CCL10, although this name is no longer in use. It is secreted by follicle-associated epithelium (FAE) such as that found around Peyer's patches, and attracts dendritic cells that possess the cell surface molecule CD11b and the chemokine receptor CCR1. CCL9 can activate osteoclasts through its receptor CCR1 suggesting an important role for CCL9 in bone resorption. CCL9 is constitutively expressed in macrophages and myeloid cells. The gene for CCL9 is located on chromosome 11 in mice.

Osteoimmunology is a field that emerged about 40 years ago that studies the interface between the skeletal system and the immune system, comprising the "osteo-immune system". Osteoimmunology also studies the shared components and mechanisms between the two systems in vertebrates, including ligands, receptors, signaling molecules and transcription factors. Over the past decade, osteoimmunology has been investigated clinically for the treatment of bone metastases, rheumatoid arthritis (RA), osteoporosis, osteopetrosis, and periodontitis. Studies in osteoimmunology reveal relationships between molecular communication among blood cells and structural pathologies in the body.

<span class="mw-page-title-main">Bone remodeling</span> Continuous turnover of bone matrix and mineral

In osteology, bone remodeling or bone metabolism is a lifelong process where mature bone tissue is removed from the skeleton and new bone tissue is formed. These processes also control the reshaping or replacement of bone following injuries like fractures but also micro-damage, which occurs during normal activity. Remodeling responds also to functional demands of the mechanical loading.

<span class="mw-page-title-main">Colony stimulating factor 1 receptor</span> Protein found in humans

Colony stimulating factor 1 receptor (CSF1R), also known as macrophage colony-stimulating factor receptor (M-CSFR), and CD115, is a cell-surface protein encoded by the human CSF1R gene. CSF1R is a receptor that can be activated by two ligands: colony stimulating factor 1 (CSF-1) and interleukin-34 (IL-34). CSF1R is highly expressed in myeloid cells, and CSF1R signaling is necessary for the survival, proliferation, and differentiation of many myeloid cell types in vivo and in vitro. CSF1R signaling is involved in many diseases and is targeted in therapies for cancer, neurodegeneration, and inflammatory bone diseases.

<span class="mw-page-title-main">Tooth resorption</span> Breakdown of the tooth root to be absorbed by the blood

Resorption of the root of the tooth, or root resorption, is the progressive loss of dentin and cementum by the action of odontoclasts. Root resorption is a normal physiological process that occurs in the exfoliation of the primary dentition. However, pathological root resorption occurs in the permanent or secondary dentition and sometimes in the primary dentition.

In bone physiology, the bone remodeling period describes the temporal duration of the basic multicellular unit (BMU) that is responsible for bone turnover. Historically, this was referred to as the sigma (σ) or sigma period, but the terminology is now outdated.